Form 8-K - Current report:
SEC Accession No. 0001078782-13-000919
Filing Date
2013-05-10
Accepted
2013-05-10 15:59:14
Documents
5
Period of Report
2013-05-06
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k051013_8k.htm 8-K 26379
2 EXHIBIT 3.1 BYLAWS f8k051013_ex3z1.htm EX-3.1 76014
3 EXHIBIT 99.1 INSIDER TRADING POLICY f8k051013_ex99z1.htm EX-99.1 28025
4 EXHIBIT 99.2 PRESS RELEASE f8k051013_ex99z2.htm EX-99.2 6117
5 IMAGE f8k051013_ex99z2001.jpg GRAPHIC 7131
  Complete submission text file 0001078782-13-000919.txt   148113
Mailing Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095
Business Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095 801-446-8802
OphthaliX, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 13833375
SIC: 2834 Pharmaceutical Preparations